Arc Institute
Germinal works by integrating AlphaFold-Multimer, which predicts protein–protein structures, with IgLM, an antibody-specific language model. By jointly optimizing structure and sequence, it redesigns CDR loops on a fixed antibody framework to target chosen epitopes.
